DeLucia, David – Trademark Portfolio

Entity Type: 01

DeLucia, David holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include IMMUNEXT. The owner is based in Lebanon, NH.

Lebanon, NH 03756

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DeLucia, David's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

32
Light Beverages (3 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does DeLucia, David have?

DeLucia, David has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.

What trademark classes does DeLucia, David file in?

DeLucia, David files trademarks across 3 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 42 (Computer & Scientific), Class 16 (Paper Goods). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.

What are DeLucia, David's most well-known trademarks?

DeLucia, David's registered trademark portfolio includes well-known marks such as IMMUNEXT. These are among 1 currently registered trademark in the portfolio.

What is DeLucia, David's trademark registration success rate?

DeLucia, David has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.